Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
SEK 3.84
(-2.04%)
SEK 3.84
(-2.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -65.93 Million SEK | 2.38% |
| 2022 | -67.44 Million SEK | -11.14% |
| 2021 | -60.68 Million SEK | -17.12% |
| 2020 | -51.81 Million SEK | -22.44% |
| 2019 | -42.31 Million SEK | -26.5% |
| 2018 | -33.45 Million SEK | -60.21% |
| 2017 | -20.87 Million SEK | 22.38% |
| 2016 | -26.89 Million SEK | -62.06% |
| 2015 | -16.59 Million SEK | 7.35% |
| 2014 | -17.91 Million SEK | 1.28% |
| 2013 | -18.14 Million SEK | -42.38% |
| 2012 | -12.74 Million SEK | -81.38% |
| 2011 | -7.02 Million SEK | -42.74% |
| 2010 | -4.92 Million SEK | -157.44% |
| 2009 | -1.91 Million SEK | -210.03% |
| 2008 | -616.83 Thousand SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -12.87 Million SEK | 24.24% |
| 2024 Q1 | -16.99 Million SEK | 15.66% |
| 2024 Q3 | -9.29 Million SEK | 24.77% |
| 2023 Q1 | -15.14 Million SEK | -97.12% |
| 2023 Q4 | -20.14 Million SEK | -29.04% |
| 2023 Q2 | -17.01 Million SEK | -12.37% |
| 2023 FY | -65.83 Million SEK | 2.38% |
| 2023 Q3 | -15.61 Million SEK | 8.23% |
| 2022 Q4 | -7.68 Million SEK | 71.59% |
| 2022 Q1 | -13.97 Million SEK | 25.12% |
| 2022 Q2 | -18.74 Million SEK | -34.17% |
| 2022 FY | -67.44 Million SEK | -11.14% |
| 2022 Q3 | -27.03 Million SEK | -44.21% |
| 2021 Q1 | -9.7 Million SEK | 21.22% |
| 2021 Q3 | -12.1 Million SEK | 40.09% |
| 2021 Q4 | -18.66 Million SEK | -54.13% |
| 2021 FY | -60.68 Million SEK | -17.12% |
| 2021 Q2 | -20.2 Million SEK | -108.25% |
| 2020 Q4 | -12.31 Million SEK | -48.61% |
| 2020 Q2 | -10.54 Million SEK | 49.69% |
| 2020 FY | -51.81 Million SEK | -22.44% |
| 2020 Q1 | -20.94 Million SEK | -62.19% |
| 2020 Q3 | -8.28 Million SEK | 21.36% |
| 2019 Q4 | -12.91 Million SEK | -41.68% |
| 2019 FY | -42.31 Million SEK | -26.5% |
| 2019 Q3 | -9.11 Million SEK | 12.87% |
| 2019 Q1 | -9.86 Million SEK | -3.86% |
| 2019 Q2 | -10.46 Million SEK | -6.07% |
| 2018 FY | -33.45 Million SEK | -60.21% |
| 2018 Q1 | -1.37 Million SEK | 69.27% |
| 2018 Q4 | -9.49 Million SEK | -32.1% |
| 2018 Q3 | -7.18 Million SEK | 53.28% |
| 2018 Q2 | -15.38 Million SEK | -1018.79% |
| 2017 FY | -20.87 Million SEK | 22.38% |
| 2017 Q4 | -4.47 Million SEK | -29.7% |
| 2017 Q3 | -3.45 Million SEK | 34.58% |
| 2017 Q2 | -5.27 Million SEK | 31.28% |
| 2017 Q1 | -7.67 Million SEK | -65.31% |
| 2016 FY | -26.89 Million SEK | -62.06% |
| 2016 Q2 | -6.24 Million SEK | 22.81% |
| 2016 Q1 | -8.08 Million SEK | -78.76% |
| 2016 Q3 | -7.91 Million SEK | -26.84% |
| 2016 Q4 | -4.64 Million SEK | 41.36% |
| 2015 Q3 | -3.77 Million SEK | -0.29% |
| 2015 Q4 | -4.52 Million SEK | -19.94% |
| 2015 FY | -16.59 Million SEK | 7.35% |
| 2015 Q2 | -3.76 Million SEK | 17.09% |
| 2015 Q1 | -4.53 Million SEK | 47.86% |
| 2014 FY | -17.91 Million SEK | 1.28% |
| 2014 Q4 | -8.7 Million SEK | -179.28% |
| 2014 Q2 | -3.5 Million SEK | -34.99% |
| 2014 Q3 | -3.11 Million SEK | 11.0% |
| 2014 Q1 | -2.59 Million SEK | 58.01% |
| 2013 Q4 | -6.17 Million SEK | -55.15% |
| 2013 Q2 | -4.33 Million SEK | -18.95% |
| 2013 Q3 | -3.98 Million SEK | 8.25% |
| 2013 FY | -18.14 Million SEK | -42.38% |
| 2013 Q1 | -3.64 Million SEK | 4.06% |
| 2012 Q4 | -3.8 Million SEK | -22.15% |
| 2012 Q2 | -2.42 Million SEK | 28.62% |
| 2012 Q1 | -3.4 Million SEK | -36.71% |
| 2012 FY | -12.74 Million SEK | -81.38% |
| 2012 Q3 | -3.11 Million SEK | -28.28% |
| 2011 Q3 | -1.24 Million SEK | 24.64% |
| 2011 Q2 | -1.64 Million SEK | 0.13% |
| 2011 Q1 | -1.64 Million SEK | -48.68% |
| 2011 Q4 | -2.48 Million SEK | -100.48% |
| 2011 FY | -7.02 Million SEK | -42.74% |
| 2010 Q2 | -867.88 Thousand SEK | 53.39% |
| 2010 FY | -4.92 Million SEK | -157.44% |
| 2010 Q3 | -1.08 Million SEK | -24.97% |
| 2010 Q1 | -1.86 Million SEK | -554.98% |
| 2010 Q4 | -1.1 Million SEK | -2.22% |
| 2009 Q2 | -394.06 Thousand SEK | 53.63% |
| 2009 Q1 | -849.77 Thousand SEK | -273.58% |
| 2009 FY | -1.91 Million SEK | -210.03% |
| 2009 Q4 | -284.3 Thousand SEK | 26.01% |
| 2009 Q3 | -384.26 Thousand SEK | 2.49% |
| 2008 FY | -616.83 Thousand SEK | 0.0% |
| 2008 Q4 | 489.56 Thousand SEK | 231.43% |
| 2008 Q3 | -372.48 Thousand SEK | 18.57% |
| 2008 Q2 | -457.43 Thousand SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 14.983% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 121.934% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 121.934% |
| Arcoma AB | 4.66 Million SEK | 1514.871% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 50.025% |
| BICO Group AB (publ) | -618.3 Million SEK | 89.336% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 267.897% |
| CellaVision AB (publ) | 167.05 Million SEK | 139.469% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | -122.961% |
| C-Rad AB (publ) | 44.24 Million SEK | 249.021% |
| Duearity AB (publ) | -25.76 Million SEK | -155.921% |
| Dignitana AB (publ) | -15.02 Million SEK | -338.793% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 30.45% |
| Getinge AB (publ) | 3.81 Billion SEK | 101.729% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 3.671% |
| Iconovo AB (publ) | -45.77 Million SEK | -44.032% |
| Integrum AB (publ) | 6.51 Million SEK | 1112.432% |
| Luxbright AB (publ) | -25.8 Million SEK | -155.51% |
| Mentice AB (publ) | -679 Thousand SEK | -9610.309% |
| OssDsign AB (publ) | -91.95 Million SEK | 28.299% |
| Paxman AB (publ) | 12.61 Million SEK | 622.49% |
| Promimic AB (publ) | -9.11 Million SEK | -623.108% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 60.916% |
| SciBase Holding AB (publ) | -53.93 Million SEK | -22.236% |
| ScandiDos AB (publ) | -13.48 Million SEK | -389.008% |
| Sectra AB (publ) | 518.49 Million SEK | 112.716% |
| Sedana Medical AB (publ) | -65.54 Million SEK | -0.589% |
| Senzime AB (publ) | -133.74 Million SEK | 50.702% |
| SpectraCure AB (publ) | -21.35 Million SEK | -208.805% |
| Stille AB | 44.95 Million SEK | 246.674% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 98.163% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 271.228% |